Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
MedChem Australia is a Biotechnology Research brand in Parkville, Victoria. Ownership is a partnership; it publishes at medchemaustralia.org. It holds three addresses on record, all in Australia. The record counts 4 people. Tagged collaboration. One Australian registration (ABN) is a confirmed match. It is listed alongside eight similar brands, mostly in Biotechnology Research.
ABN67104785775
| MEDCHEM PTY LIMITED | ABN 67104785775 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
MedChem Australia's mission is to work with the Australian biomedical research and biotech community to develop new medicines through creativity and collaboration. MedChem Australia will provide expert medicinal chemistry & DMPK capability plus drug discovery mentorship at subsidised cost to enhance, accelerate, and enable the development of new small molecule therapeutics. Projects to receive subsidised support will be selected through a competitive and independent application process. Projects should be innovative, address an unmet medical need, and contain existing chemistry.
MedChem Australia will have an annual call for applications, with Australian Universities, Medical Research Institutes, and SMEs eligible to apply. Discussion of applications with MedChem Australia prior to submission is encouraged. Further information on how to apply and engage with MedChem Australia is available on our website.
MedChem Australia brings together three of the nation’s top medicinal chemistry groups from Monash University, WEHI and the University of Sydney, each with a track record of success in commercially-focused drug discovery. Projects will be allocated to one of these three MedChem Australia Nodes where MedChem Australia scientists will help plan the chemistry strategy for the project, design compounds, make compounds, generate in vitro & in vivo DMPK data, and drive the project forward.
MedChem Australia was established with $15 million in funding from the Federal Government’s Medical Research Future Fund, Therapeutic Innovation Australia (TIA) and the three nodes, with an initial runway of 5 years.
Please follow MedChem Australia and stay tuned for updates regarding this exciting initiative.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One New South Wales entity on the ABR. MEDCHEM PTY LIMITED (ABN 67 104 785 775), high confidence.
The record holds 4 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Three addresses on record, Australia only. Primary: 399 Royal Pde, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052.
None linked to this brand.
Five tags on the brand's own list, among them collaboration.
Eight peer profiles on record: WEHI (Walter and Eliza Hall Institute of Medical Research) and CSL.